Roche Submits Tamiflu sNDA For Pediatric Capsules
This article was originally published in The Pink Sheet Daily
Executive Summary
If approved, children’s capsules would be manufactured in 30 mg and 45 mg doses; adult dose is 75 mg.
You may also be interested in...
Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand
Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.
Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand
Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.
Tamiflu U.S. Labeling Adopts Japanese Warnings
Neuropsychiatric adverse event reports for Roche's antiviral jump in most recent review, prompting FDA staff to suggest a labeling change.